Table 2.

Adjusted odds for 25OHD insufficiency (15 to 30 ng/ml) and deficiency (<15 ng/ml) among the participants of the NHANES III with CKDa

ParameterCKD (OR [95% CI])
Analysis 1b
25OHD 15 to 30 ng/ml1.13 (0.92 to 1.39)
25OHD <15 ng/ml1.32 (1.03 to 1.72)
Analysis 2c
25OHD 15 to 30 ng/ml1.15 (0.92 to 1.44)
25OHD <15 ng/ml1.39 (1.09 to 1.77)
  • a 25OHD, 25-hydroxyvitamin D.

  • b Adjusted for age, gender, race/ethnicity, BMI, vitamin D intake (diet and supplements), medical insurance, educational level, family income, and month of the year (n = 12,620).

  • c Adjusted for age, gender, race/ethnicity, BMI, vitamin D intake (diet and supplements), medical insurance, educational level, family income, month of the year, current smoking, hypertension, diabetes, non-HDL cholesterol, serum CRP, and serum albumin (n = 12,475).